Cargando…

Endocrine adverse events related to immune-oncology agents: retrospective experience of a single institution

BACKGROUND: Immune-oncology agents (IOA) represent a turning point in the treatment of several solid tumors (ST). Although their toxicity compares favorably with other treatments, IOA associate immune-related adverse events (IR-AE), among which endocrine-related AE stand out. We retrospectively eval...

Descripción completa

Detalles Bibliográficos
Autores principales:	España, Sofia, Pérez Montes de Oca, Alejandra, Marques-Pamies, Montserrat, Cucurull, Marc, Domenech, Marta, Velarde, José María, Salinas, Isabel, Moran, Teresa, Etxaniz, Olatz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082288/ https://www.ncbi.nlm.nih.gov/pubmed/32206558 http://dx.doi.org/10.21037/tlcr.2019.12.17

Ejemplares similares

Adverse effects of endocrine therapy in breast cancer: single institute experience
por: Sert, Fatma, et al.
Publicado: (2014)

1591P Immune response after vaccination against SARS-COV-2 in lung cancer (LC) patients (p). Prospective study in the Medical Oncology Department at the Catalan Institute of Oncology-Badalona, Spain: COVID-lung vaccine
por: Felip, E., et al.
Publicado: (2021)

Small-Cell Lung Cancer Long-Term Survivor Patients: How to Find a Needle in a Haystack?
por: Plaja, Andrea, et al.
Publicado: (2021)

SEOM—GECOD clinical guideline for unknown primary cancer (2021)
por: Losa, Ferrán, et al.
Publicado: (2022)

Neural Crest Stem Cells from Dental Tissues: A New Hope for Dental and Neural Regeneration
por: Ibarretxe, Gaskon, et al.
Publicado: (2012)

Immune Checkpoint Inhibitors: A Promising Treatment Option for Metastatic Castration-Resistant Prostate Cancer?
por: Ruiz de Porras, Vicenç, et al.
Publicado: (2021)

Oncology providers’ perspectives on endocrine therapy prescribing and management
por: Wheeler, Stephanie B, et al.
Publicado: (2016)

Endocrine Oncology: the home for translational research in cancer and hormones
por: Castaño, Justo P
Publicado: (2023)

Immune-checkpoint inhibitors for lung cancer patients amid the COVID-19 pandemic: a case report of severe meningoencephalitis after switching to an extended-interval higher flat-dose nivolumab regimen
por: Pous, Anna, et al.
Publicado: (2021)

Integration of endocrine therapy with targeted agents
por: Johnston, Stephen RD
Publicado: (2008)

PSA Kinetics as Prognostic Markers of Overall Survival in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Abiraterone Acetate
por: España, Sofia, et al.
Publicado: (2020)

Real-world data on T-DM1 efficacy – results of a single-center retrospective study of HER2-positive breast cancer patients
por: Hardy-Werbin, Max, et al.
Publicado: (2019)

Endocrine-Disrupting Chemicals and Their Adverse Effects on the Endoplasmic Reticulum
por: Kim, Kangmin, et al.
Publicado: (2022)

New endocrine agents, guidelines for future development.
por: Judson, I. R.
Publicado: (1989)

Pharmacogenetics and pharmacogenomics of endocrine agents for breast cancer
por: Ingle, James N
Publicado: (2008)

Self-Adaptable Tropos Catalysts
por: Diéguez, Montserrat, et al.
Publicado: (2021)

Moving towards Personalized Medicine in Muscle-Invasive Bladder Cancer: Where Are We Now and Where Are We Going?
por: Pardo, Juan Carlos, et al.
Publicado: (2020)

Adverse drug reactions associated with the use of biological agents
por: Machado-Alba, Jorge Enrique, et al.
Publicado: (2020)

Immune checkpoint inhibitors, endocrine adverse events, and outcomes of melanoma
por: Karhapää, Hanna, et al.
Publicado: (2022)

Adverse Endocrine-Related Effects of Pembrolizumab Precipitating Severe Hyponatremia
por: Baldawi, Muaamar B, et al.
Publicado: (2022)

The Uncharted Landscape of Rare Endocrine Immune-Related Adverse Events
por: Mytareli, Chrysoula, et al.
Publicado: (2023)

Adverse Events of Oncologic Immunotherapy and Their Management
por: Barber, Fedricker Diane
Publicado: (2019)

Hypoglycemia after bariatric surgery: importance of exhaustive hormonal study
por: Perez-Montes de Oca, Alejandra, et al.
Publicado: (2021)

Analysis of Tonguing and Blowing Actions During Clarinet Performance
por: Pàmies-Vilà, Montserrat, et al.
Publicado: (2018)

The influence of the vocal tract on the attack transients in clarinet playing
por: Pàmies-Vilà, Montserrat, et al.
Publicado: (2020)

Agent‐Based Modeling in Systems Pharmacology
por: Cosgrove, J, et al.
Publicado: (2015)

From target analysis to suspect and non-target screening of endocrine-disrupting compounds in human urine
por: Musatadi, Mikel, et al.
Publicado: (2022)

The COVID-19 pandemic did not adversely affect clinical trial enrollment in gynecologic oncology trials at a single academic institution
por: Bailey, Courtney, et al.
Publicado: (2022)

Política laboral y corporativismo en el Estado de México : 1934-1940 /
por: Montes de Oca N., Elvia (Montes de Oca Navas), 1948-
Publicado: (2000)

Bibliografía del Estado de México
por: Montes de Oca N., Elvia (Montes de Oca Navas), 1948-
Publicado: (1995)

Synaptic neuron-astrocyte communication is supported by an order of magnitude analysis of inositol tris-phosphate diffusion at the nanoscale in a model of peri-synaptic astrocyte projection
por: Montes de Oca Balderas, Pavel, et al.
Publicado: (2018)

Spermatocytic seminoma at the National Institute of Oncology in Morocco
por: Raiss, Ghizlane G, et al.
Publicado: (2011)

Spermatocytic seminoma at the national institute of oncology in Morocco
por: Raiss, Ghizlane G, et al.
Publicado: (2011)

Endocrine immune-related adverse events: a double-edged sword?
por: Rengarajan, Michelle, et al.
Publicado: (2021)

Late adverse events in patients with pelvic cancer after oncologic treatment—intervention and treatment effect
por: Iselius, Sofia, et al.
Publicado: (2023)

1596P SERONCOVID: Seroconversion in solid-tumor cancer patients (p) after COVID-19 diagnosis
por: Pous, A., et al.
Publicado: (2021)

Evaluation of the clinical Index of Stable febrile neutropenia risk stratification system for management of febrile neutropenia in gynecologic oncology patients
por: Monuszko, Karen A., et al.
Publicado: (2021)

Institutional guidelines and ongoing studies in management of liver tumours: the experience of the European Institute of Oncology
por: Biffi, R, et al.
Publicado: (2008)

Reconstruction of Oncologic Sternectomy Defects: Lessons Learned from 60 Cases at a Single Institution
por: Banuelos, Joseph, et al.
Publicado: (2019)

European Institute of Oncology project for lung cancer screening
por: Bellomi, Massimo
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_3ve5hd8q4noigg81dhs9bv1hsm